(Q39448864)

12 September 2017

Long-term treatment of cancer pain with transdermal fentanyl (English)

1 reference

12 September 2017

0 references

1 reference

Donner B

1

1 reference

12 September 2017

Zenz M

series ordinal

2

1 reference

12 September 2017

Strumpf M

series ordinal

3

1 reference

12 September 2017

Raber M

series ordinal

4

1 reference

12 September 2017

1 March 1998

1 reference

Journal of Pain and Symptom Management

12 September 2017

1 reference

12 September 2017

15

1 reference

12 September 2017

168-175

1 reference

12 September 2017

3

1 reference

Transdermal fentanyl use in hospice home-care patients with chronic cancer pain

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl: seeding trial in patients with chronic cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl for pain control in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl for chronic cancer pain: detailed case reports and the influence of confounding factors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl in combination with initial intravenous dose titration by patient-controlled analgesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl: clinical development in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

[Long-term therapy of cancer pain. A controlled study on buprenorphine]

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

[Retard morphine in the long-term therapy of severe tumor pain]

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Guidelines for the clinical use of transdermal fentanyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose finding--a pilot study in 20 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

[Oral administration of slow-release naloxone for prevention of constipation but not analgesia following oral morphine.].

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900361-8

7 January 2021

10.1016/S0885-3924(97)00361-8

Identifiers

DOI

1 reference

12 September 2017

1 reference